Judge Dismisses MedImmune's Patent Suit Vs. Genentech

Law360 (April 24, 2004, 12:00 AM EDT) -- A U.S. District Court judge has dismissed MedImmune patent lawsuit against biotech company Genentech over technology to create drugs using antibody molecules.

U.S. District Judge Mariana Pfaelzer in the U.S. District Court for the Central District of California ruled the case cannot be considered because there is no “actual controversy” between Genentech and MedImmune.

“Because MedImmune is a licensee in good standing, and because the relief MedImmune seeks is declaratory judgment, this court has no choice but to dismiss this case for lack of subject matter jurisdiction,” Pfaelzer wrote in her 12-page opinion.

MedImmune had sued to invalidate the Genentech patent...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS